Integra LifeSciences Holdings Corp. (IART)

55.94
0.22 0.39
NASDAQ : Health Technology
Prev Close 55.72
Open 56.04
Day Low/High 54.34 / 56.04
52 Wk Low/High 41.51 / 58.17
Volume 637.32K
Avg Volume 472.10K
Exchange NASDAQ
Shares Outstanding 78.96M
Market Cap 4.40B
EPS 0.80
P/E Ratio 67.95
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CG, FLO, GNW, IART, LITE, MX, PDVW, PFPT, STO, TTWO Downgrades: AINV, BCO, BZH, CRCM, GSIT, GSK, IESC, ISRL, MLAB, MTCH, NEU, NNN, PZN, SGA Initiations: TRVG Read on to get TheStreet Quant Ratings' detailed report:

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment

We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.

IART: Insiders vs. Shorts

IART: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/13/2017 settlement date, and Integra LifeSciences Holdings Corp is one of the most shorted stocks of the Russell 3000, based on 10.41 "days to cover" versus the median component at 5.98. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACTG, FCN, OFC Downgrades: ABX, AVT, GCAP, IART, KKR, MAT, NEP, RRD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Integra LifeSciences Launches Revize™/ Revize™-X Collagen Matrix For Plastic And Reconstructive Surgery

Integra LifeSciences Launches Revize™/ Revize™-X Collagen Matrix For Plastic And Reconstructive Surgery

Revize and Revize-X are collagen matrices for plastic and reconstructive surgery, derived from fetal bovine dermis, available in solid and 2:1 meshed configurations

Integra LifeSciences Launches SurgiMend® PRS Meshed Collagen Matrix For Plastic And Reconstructive Surgery

Integra LifeSciences Launches SurgiMend® PRS Meshed Collagen Matrix For Plastic And Reconstructive Surgery

SurgiMend PRS Meshed is a collagen matrix for soft tissue reconstruction, featuring a 2:1 meshing pattern

Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According To A Study Recently Published In The Journal Of Health Economics And Outcomes Research

Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According To A Study Recently Published In The Journal Of Health Economics And Outcomes Research

Hospitals can reduce costs of cerebrospinal fluid (CSF) leaks after posterior fossa surgeries by using DuraSeal® instead of fibrin glue

IART: Insiders vs. Shorts

IART: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/14/2017 settlement date, and Integra LifeSciences Holdings Corp is one of the most shorted stocks of the Russell 3000, based on 9.31 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Johnson & Johnson Signals It Could Make Additional Divestitures

Johnson & Johnson Signals It Could Make Additional Divestitures

CFO Dominic Caruso said on an earnings call that ongoing reviews of the company's portfolio "suggest we currently have more opportunity to divest some nonstrategic businesses."

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

Integra LifeSciences Launches SurgiMend® MP Collagen Matrix For Hernia Repair

SurgiMend MP is a collagen matrix for soft tissue reconstruction, featuring a highly macroporous design

TheStreet Quant Rating: A (Buy)